Page 4 - Best hematologist-oncologists: TOP 171 doctors

Dr. Herishanu Yair is a leading hematologist with 10+ awards for groundbreaking research in chronic lymphocytic leukemia (CLL) at Sourasky Medical Center.

• Specializes in CLL – the most common adult leukemia
• Recipient of the prestigious Klitzberg Oncology Award
• Member of both Israeli and American Hematology Associations
• Extensive training at top Israeli medical institutions
• Published researcher with grants from Israeli Science Foundation

Professor Drach has performed 1,100+ oncology procedures and led the Multiple Myeloma and Malignant Lymphoma program at Vienna's University Hospital – one of Europe's largest.

• Specializes in hematologic oncology with of experience
• Former head physician at Vienna's University Hospital of Internal Medicine I
• Published 120+ scientific papers on hematology and oncology
• Board member of Austrian Society of Hematology and Oncology
• Offers second opinions and pre-surgical therapy optimization

Dr. Carmen Martínez Chamorro specializes in adult bone marrow transplants for leukemia, lymphoma, and myeloma at Quironsalud Madrid.

• Deputy Head of Hematology at Quironsalud Madrid
• Author of 20 medical articles and participant in 60 conferences
• Trained at La Princesa University Hospital in Madrid
• Recipient of the National Prize for Research in Surgery

Professor Hasan Atilla Ozkan leads the Turkish Therapeutic Apheresis Association and specializes in stem cell transplantation at VM Medical Park Pendik Hospital.

• 23 years of experience of experience in hematology and bone marrow transplantation
• Certified in autologous and allogeneic stem cell transplantation by EBMT
• Current professor at Yeditepe University Faculty of Medicine
• Recipient of the Young Researcher Award in Therapeutic Apheresis

Assoc. Prof. Dr. Özlem Köroğlu is a specialist in Physical Medicine and Rehabilitation at Memorial Ankara Hospital (2024–present). She previously served as a faculty member at Gaziler Physical Therapy and Rehabilitation Training and Research Hospital (2016–2024). She was Chief of the Physical Medicine and Rehabilitation Clinic at Elazığ Military Hospital (2011–2015). She earned her MD in 2003 from the GATA Faculty of Medicine. She completed her PM&R residency in 2011.

Her credentials include Ministry of Health–approved certified prolotherapy training. She has taught Prolotherapy and PRP (2022) and Knee Prolotherapy and Campinject (2019). She also taught GETAT and Dextrose Prolotherapy (2018) and ISPRM Ultrasound (2009). She has additional training in musculoskeletal ultrasound, neural therapy, lumbar injections and manipulation, and botulinum toxin treatment for the spastic hand. She attended the Euro‑Mediterranean PRM School in Italy (2010). She is a member of the Turkish Society of PM&R, the Turkish Society for Research and Fight Against Rheumatism, the Association of PM&R Specialists of Türkiye, the Spinal Cord Diseases Association, and the Ankara Medical Chamber.

Dr. Osman Ilhan is a Professor of Internal Diseases. He earned his medical degree at Ankara University in 1978. He completed his specialization in Internal Diseases there in 1982. He became an Associate Professor in 1990 and a Professor in 1996.

He served as a professor at Ankara University from 1997 to 2022. He has worked at Lokman Hekim Akay Hospital since 2023. Earlier, he held roles at MD Anderson Cancer Center (1996–1997), Ankara University (1978–1983; 1988–1995), GATA (1984–1985), and Ulus Hospital (1985–1988).

1,100+ lymphoma procedures performed – Prof. Weidmann heads Hematology at Nordwest Clinic, a leading center for blood disorders.

• Specializes in both Hodgkin's and non-Hodgkin lymphoma care
• Professor with extensive academic and clinical expertise
• 36 years of experience focused on blood disorder treatments
• Leads one of Germany's top hematology departments

Forbes-listed as one of Israel's best doctors – Dr. Goldstein leads Pediatric Oncology at Hadassah Medical Center.

• Specializes in pediatric hemato-oncology for over 27 years of experience
• Expert in retinoblastoma and precision medicine approaches
• Performs haploidentical bone marrow transplants for children
• Member of four international pediatric oncology associations

Specializes in hematologic cancers and advanced bone marrow transplants – Dr. Alemdar combines academic excellence at Akdeniz University with 20 years of experience of clinical practice.

• Board-certified in Medical Oncology with additional Internal Medicine training
• Expert in CAR T-cell therapy and haploidentical stem cell transplants
• Member of the Turkish Medical Oncology Association
• Works at JCI-accredited Medical Park Antalya Hospital Complex

Prof. Reuven Or leads the Department of Hematology and Bone Marrow Transplantation at Hadassah – a pioneer in cancer immunotherapy and cell therapy.

• specializing in bone marrow transplants and hematologic cancers
• Medical Director of Israel's National Blood Bank and Public Bone Marrow Registry
• Recipient of the prestigious Menachem Begin Prize for medical achievements
• Trained at top institutions in Italy and the US
• Published multiple research articles in medical journals

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

 Mali interdisciplinary hospital is integrating conventional, regenerative and precision medicine. It divides into 11 departments, there are 35 beds in total, including 12 intensive care beds, 23 general beds, 2 emergency and operating rooms, 1 plastic surgical room, 1 Gastro-colonoscopic room. Focus on round-trip treatment with modern medical technology to reduce the cost of hospitalization and the healing time. It also integrating regenerative medicine to repair the body and precision medicine for preventing and treating chronic non-communicable diseases (NCDs) with better results, we provide these services in a greenery atmosphere. Allowing clients to receive the following benefits.

1. Far away from NCDs & It’s complication

2. Good quality of life

3. Youthful lively life

4. Longevity

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.